Yang Zhao

Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer

Baohui Han, Kai Li, Qiming Wang et al. · JAMA Oncology · 2018 · 620 citations · Full text

Medicine, Oncology, Pharmacology +17

Circulating Mitochondrial DNA in Patients in the ICU as a Marker of Mortality: Derivation and Validation

Kiichi Nakahira, Sunyoung Kyung, Angela J. Rogers et al. · PLoS Medicine · 2013 · 449 citations · Full text

Medicine, Immunology, Molecular Genetics +15

Development and validation of an immune gene-set based Prognostic signature in ovarian cancer

Sipeng Shen, Guanrong Wang, Ruyang Zhang et al. · EBioMedicine · 2018 · 303 citations · Full text

Medicine, Immunology, Oncology +17

Th17 Immunity in Patients with Allergic Asthma

Yang Zhao, Jiong Yang, Yadong Gao et al. · International Archives of Allergy and Immunology · 2009 · 268 citations · Full text

Life Sciences, Immunology, Pathology +17

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma

Minke He, Run-Bin Liang, Yang Zhao et al. · Therapeutic Advances in Medical Oncology · 2021 · 214 citations · Full text

Medicine, Oncology, Pharmacotherapy +16